Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'D-2 RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 583 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kapp, OH; Siemion, J; Kuo, J; Johnson, BA; Shankaran, V; Reba, RC; Mukherjee, J
      Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: a molecular modeling study

      JOURNAL OF MOLECULAR MODELING
    2. Newbold, P; Jackson, DM; Young, A; Dougall, IG; Ince, F; Rocchiccioli, KMS; Holt, PR
      Dual D-2 dopamine receptor and beta(2)-adrenoceptor agonists for the modulation of sensory nerves in COPD

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    3. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
      Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    4. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    5. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    6. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    7. Shen, DHY; Kloos, RT; Mazzaferri, EL; Jhiang, SM
      Sodium iodide symporter in health and disease

      THYROID
    8. Ishiwata, K; Kobayashi, T; Kawamura, K; Matsuno, K; Senda, M
      [C-11]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [C-11]SA4503 binding was not by raclopride

      NUCLEAR MEDICINE AND BIOLOGY
    9. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    10. Mercier, D; Falardeau, P; Levesque, D
      Autoreceptor preference of dopamine D-2 receptor agonist correlates with preferential coupling to cyclic AMP

      NEUROREPORT
    11. Lanser, MG; Ellenbroek, BA; Zitman, FG; Heeren, DJ; Cools, AR
      The role of medial prefrontal cortical dopamine in spontaneous flexibilityin the rat

      BEHAVIOURAL PHARMACOLOGY
    12. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    13. Wadenberg, MLG; Soliman, A; VanderSpek, SC; Kapur, S
      Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

      NEUROPSYCHOPHARMACOLOGY
    14. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
      Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"

      NEUROPSYCHOPHARMACOLOGY
    15. Okauchi, T; Suhara, T; Maeda, J; Kawabe, K; Obayashi, S; Suzuki, K
      Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET

      SYNAPSE
    16. Joel, D
      Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease

      MOVEMENT DISORDERS
    17. Ohngemach, S; Feldkaemper, M; Schaeffel, F
      Pineal control of the dopamine D-2-receptor gene and dopamine release in the retina of the chicken and their possible relation to growth rhythms of the eye

      JOURNAL OF PINEAL RESEARCH
    18. Higgins, DS
      Chorea and its disorders

      NEUROLOGIC CLINICS
    19. Csende, F
      A simple procedure for synthesis of roxindole, a dopamine D-2-receptor agonist

      ARCHIV DER PHARMAZIE
    20. Freeman, A; Ciliax, B; Bakay, R; Daley, J; Miller, RD; Keating, G; Levey, A; Rye, D
      Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models

      ANNALS OF NEUROLOGY
    21. Tranquart, F; Saliba, E; Barantin, L; Lanneau, M; Simmer, L; Guilloteau, D; Baulieu, JL
      D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT

      CLINICAL NUCLEAR MEDICINE
    22. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    23. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    24. Yasuno, F; Suhara, T; Sudo, Y; Yamamoto, M; Inoue, M; Okubo, Y; Suzuki, K
      Relation among dopamine D-2 receptor binding, obesity and personality in normal human subjects

      NEUROSCIENCE LETTERS
    25. Bullock, CM; Li, C; Li, M; Bermak, JC; Zhou, QY
      Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    26. Mawlawi, O; Martinez, D; Slifstein, M; Broft, A; Chatterjee, R; Hwang, DR; Huang, YY; Simpson, N; Ngo, K; Van Heertum, R; Laruelle, M
      Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D-2 receptor parameter measurements inventral striatum

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    27. Prasad, BM; Amara, SG
      The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage

      JOURNAL OF NEUROSCIENCE
    28. King, MA; Bradshaw, S; Chang, AH; Pintar, JE; Pasternak, GW
      Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system

      JOURNAL OF NEUROSCIENCE
    29. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    30. Manzanedo, C; Serrano, A; Aguilar, MA; Rodriguez-Arias, M; Minarro, J
      Effects of CGS 10746B on hyperactivity and place preference induced by morphine

      BEHAVIOURAL BRAIN RESEARCH
    31. Feigin, A; Leenders, KL; Moeller, JR; Missimer, J; Kuenig, G; Spetsieris, P; Antonini, A; Eidelberg, D
      Metabolic network abnormalities in early Huntington's disease: An [F-18]FDG PET study

      JOURNAL OF NUCLEAR MEDICINE
    32. Urbain, JLC
      Invited commentary - Reporter genes and imagene

      JOURNAL OF NUCLEAR MEDICINE
    33. Davidson, M
      Long-term safety of risperidone

      JOURNAL OF CLINICAL PSYCHIATRY
    34. Anghelescu, I; Germeyer, S; Muller, MJ; Klawe, C; Singer, P; Dahmen, N; Wetzel, H; Himmerich, H; Szegedi, A
      No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    35. Baker, RW; Osman, J; Bodnar, RJ
      Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    36. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    37. Harvey, BH; Scheepers, A; Brand, L; Stein, DJ
      Chronic inositol increases striatal D-2 receptors but does not modify dexamphetamine-induced motor behavior - Relevance to obsessive-compulsive disorder

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    38. Kapur, S; Remington, G
      Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia

      ANNUAL REVIEW OF MEDICINE
    39. Werkman, TR; Kruse, CG; Nievelstein, H; Long, SK; Wadman, WJ
      In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs

      NEUROPHARMACOLOGY
    40. Inoue, M; Suhara, T; Sudo, Y; Okubo, Y; Yasuno, F; Kishimoto, T; Yoshikawa, K; Tanada, S
      Age-related reduction of extrastriatal dopamine D-2 receptor measured by PET

      LIFE SCIENCES
    41. Kim, HJ; Koh, PO; Kang, SS; Paik, WY; Choi, WS
      The localization of dopamine D2 receptor mRNA in the human placenta and the anti-angiogenic effect of apomorphine in the chorioallantoic membrane

      LIFE SCIENCES
    42. Thanos, PK; Volkow, ND; Freimuth, P; Umegaki, H; Ikari, H; Roth, G; Ingram, DK; Hitzemann, R
      Overexpression of dopamine D2 receptors reduces alcohol self-administration

      JOURNAL OF NEUROCHEMISTRY
    43. Rahman, S; McBride, WJ
      D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA)

      JOURNAL OF NEUROCHEMISTRY
    44. Wilson, J; Lin, H; Fu, DY; Javitch, JA; Strange, PG
      Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation

      JOURNAL OF NEUROCHEMISTRY
    45. Ichikawa, J; Ishii, H; Bonaccorso, S; Fowler, WL; O'Laughlin, IA; Meltzer, HY
      5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-inducedcortical dopamine release

      JOURNAL OF NEUROCHEMISTRY
    46. Wurch, T; Matsumoto, A; Pauwels, PJ
      Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins

      FEBS LETTERS
    47. Johnston, CA; Cumbay, MG; Vortherms, TA; Watts, VJ
      Adrenergic agonists induce heterologous sensitization of adenylate cyclasein NS20Y-D-2L cells

      FEBS LETTERS
    48. Sugimoto, Y; Ohkura, M; Inoue, K; Yamada, J
      Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. Hasegawa, M; Adachi, K; Nakamura, S; Sato, M; Waddington, JL; Koshikawa, N
      Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D-1-like receptors in jaw movements

      EUROPEAN JOURNAL OF PHARMACOLOGY
    50. Tomiyama, K; McNamara, FN; Clifford, JJ; Kinsella, A; Koshikawa, N; Waddington, JL
      Topographical assessment and pharmacological characterization of orofacialmovements in mice: dopamine D-1-like vs. D-2-like receptor regulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    51. Gao, X; Zhang, YQ; Wu, GC
      Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    52. Tahar, AH; Ekesbo, A; Gregoire, L; Bangassoro, E; Svensson, KA; Tedroff, J; Bedard, PJ
      Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys

      EUROPEAN JOURNAL OF PHARMACOLOGY
    53. Curran, MP; Perry, CM
      Amisulpride - A review of its use in the management of schizophrenia

      DRUGS
    54. Bhana, N; Foster, RH; Olney, R; Plosker, GL
      Olanzapine - An updated review of its use in the management of schizophrenia

      DRUGS
    55. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
      Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    56. Yoshikawa, T; Yoshida, N; Oka, M
      The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    57. Greba, Q; Gifkins, A; Kokkinidis, L
      Inhibition of amygdaloid dopamine D-2 receptors impairs emotional learningmeasured with fear-potentiated startle

      BRAIN RESEARCH
    58. Konradi, C; Heckers, S
      Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia

      BIOLOGICAL PSYCHIATRY
    59. Bairam, A; Kinkead, R; Marchal, F
      Age-dependent effect of domperidone on dopamine release by the hypoxic carotid body in the rabbit

      BIOLOGY OF THE NEONATE
    60. Foley, JF; Kelley, LP; Kinsella, BT
      Prostaglandin D-2 receptor-mediated desensitization of the alpha isoform of the human thromboxane A(2) receptor

      BIOCHEMICAL PHARMACOLOGY
    61. Hubl, D; Kleinlogel, H; Frohlich, L; Weinandi, T; Maurer, K; Holstein, W; Czekalla, J; Dierks, T
      Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine

      PSYCHOPHARMACOLOGY
    62. Yasuno, F; Suhara, T; Okubo, Y; Sudo, Y; Inoue, M; Ichimiya, T; Tanada, S
      Dose relationship of limbic-cortical D-2-dopamine receptor occupancy with risperidone

      PSYCHOPHARMACOLOGY
    63. Lena, I; Dhotel, H; Garbay, C; Dauge, V
      Involvement of D-2 dopamine receptors in the opposing effects of two CCK-Bagonists in a spatial recognition memory task: role of the anterior nucleus accumbens

      PSYCHOPHARMACOLOGY
    64. Goldstein, JM
      The new generation of antipsychotic drugs: how atypical are they?

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    65. Loh, EW; Higuchi, S; Matsushita, S; Murray, R; Chen, CK; Ball, D
      Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population

      MOLECULAR PSYCHIATRY
    66. Jalaie, M; Lipkowitz, KB
      Published force field parameters for molecular mechanics, molecular dynamics, and Monte Carlo simulations

      REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 14
    67. Hwang, DR; Kegeles, LS; Laruelle, M
      (-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors

      NUCLEAR MEDICINE AND BIOLOGY
    68. Samochowiec, J; Ladehoff, M; Pelz, J; Smolka, M; Schmidt, LG; Rommelspacher, H; Finckh, U
      Predominant influence of the 3 '-region of dopamine D-2 receptor gene (DRD2) on the clinical phenotype in German alcoholics

      PHARMACOGENETICS
    69. Ogawa, O; Umegaki, H; Ishiwata, K; Asai, Y; Ikari, H; Oda, K; Toyama, H; Ingram, DK; Roth, GS; Iguchi, A; Senda, M
      In vivo imaging of adenovirus-mediated over-expression of dopamine D-2 receptors in rat striatum by positron emission tomography

      NEUROREPORT
    70. Terasmaa, A; Andbjer, B; Fuxe, K; Rinken, A
      Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes

      NEUROREPORT
    71. Perachon, S; Betancur, C; Pilon, C; Rostene, W; Schwartz, JC; Sokoloff, P
      Role of dopamine D-3 receptors in thermoregulation: a reappraisal

      NEUROREPORT
    72. Dringenberg, HC; Wightman, M; Beninger, RJ
      The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats

      BEHAVIOURAL PHARMACOLOGY
    73. Prinssen, EPM; Koek, W; Colpaert, FC; Kleven, MS
      Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced

      BEHAVIOURAL PHARMACOLOGY
    74. Oades, RD; Rao, ML; Bender, S; Sartory, G; Muller, BW
      Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D-2-receptor occupancy

      BEHAVIOURAL PHARMACOLOGY
    75. Siemiatkowski, M; Sienkiewicz-Jarosz, H; Czlonkowska, AI; Szyndler, J; Bidzinski, A; Plaznik, A
      The effects of dopamine D-2 receptor ligands on novelty-induced behavior in the rat open field test

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    76. Kroncke, KD; Carlberg, C
      Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide

      FASEB JOURNAL
    77. Tsukada, H; Harada, N; Nishiyama, S; Ohba, H; Sato, K; Fukumoto, D; Kakiuchi, T
      Ketamine decreased striatal [C-11]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in themonkey brain: Multiparametric PET studies combined with microdialysis analysis

      SYNAPSE
    78. Pinborg, LH; Videbaek, C; Knudsen, GM; Swahn, CG; Halldin, C; Friberg, L; Paulson, OB; Lassen, NA
      Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion

      SYNAPSE
    79. Weissenborn, K; Berding, G; Kostler, H
      Altered striatal dopamine D-2 receptor density and dopamine transport in apatient with hepatic encephalopathy

      METABOLIC BRAIN DISEASE
    80. Grevle, L; Guzey, C; Hadidi, H; Brennersted, R; Idle, JR; Aasly, J
      Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease

      MOVEMENT DISORDERS
    81. Xu, XH; Stewart, JT
      Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    82. Willson, VJC; Preston, JR; Lockley, WJS; Mather, A; Singh, J; Wilkinson, D
      A RIA combined with SPE for the determination of a dual D-2-receptor and beta(2)-adrenoceptor agonist, AR-C68397XX, in human plasma

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    83. Chong, SA; Remington, G
      Clozapine augmentation: Safety and efficacy

      SCHIZOPHRENIA BULLETIN
    84. Tahar, AH; Gregoire, L; Bangassoro, E; Bedard, PJ
      Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys

      CLINICAL NEUROPHARMACOLOGY
    85. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
      Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    86. Levens, N; Green, TA; Akins, CK; Bardo, MT
      Dopamine D-2-like receptor binding in the brain of male Japanese quail (Coturnix japonica)

      NEUROSCIENCE LETTERS
    87. Wong, AHC; Knapp, MGL; Van Tol, HHM
      Dopamine receptor gene transfer into rat striatum using a recombinant adenoviral vector: rotational behaviour

      NEUROSCIENCE LETTERS
    88. Araki, T; Tanji, H; Fujihara, K; Kato, H; Imai, Y; Mizugaki, M; Itoyama, Y
      Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats

      JOURNAL OF NEURAL TRANSMISSION
    89. Kusumi, I; Takahashi, Y; Suzuki, K; Kameda, K; Koyama, T
      Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D-2 and serotonin 5-HT2A receptors in the rat brain

      JOURNAL OF NEURAL TRANSMISSION
    90. Zahniser, NR; Simosky, JK; Mayfield, RD; Negri, CA; Hanania, T; Larson, GA; Kelly, MA; Grandy, DK; Rubinstein, M; Low, MJ; Fredholm, BB
      Functional uncoupling of adenosine A(2A) receptors and reduced response tocaffeine in mice lacking dopamine D-2 receptors

      JOURNAL OF NEUROSCIENCE
    91. Meisenzahl, EM; Dresel, S; Frodl, T; Schmitt, GJE; Preuss, UW; Rossmuller, B; Tatsch, K; Mager, T; Hahn, K; Moller, HJ
      D-2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study

      JOURNAL OF PSYCHOPHARMACOLOGY
    92. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    93. Matochik, JA; Chefer, SI; Lane, MA; Woolf, RI; Morris, ED; Ingram, DK; Roth, GS; London, ED
      Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging

      NEUROBIOLOGY OF AGING
    94. Horacek, J
      Novel antipsychotics and extrapyramidal side effects. Theory and reality

      PHARMACOPSYCHIATRY
    95. Huey, KA; Powell, FL
      Time-dependent changes in dopamine D-2-receptor mRNA in the arterial chemoreflex pathway with chronic hypoxia

      MOLECULAR BRAIN RESEARCH
    96. Muruganandam, AV; Ghosal, S; Bhattacharya, SK
      The role of xanthones in the antidepressant activity of Hypericum perforatum involving dopaminergic and serotonergic systems

      BIOGENIC AMINES
    97. Smith, Y; Kieval, JZ
      Anatomy of the dopamine system in the basal ganglia

      TRENDS IN NEUROSCIENCES
    98. Varrone, A; Fujita, M; Verhoeff, NPLG; Zoghbi, SS; Baldwin, RM; Rajeevan, N; Charney, DS; Seibyl, JP; Innis, RB
      Test-retest reproducibility of extrastriatal dopamine D-2 receptor imagingwith [I-123]epidepride SPECT in humans

      JOURNAL OF NUCLEAR MEDICINE
    99. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    100. Stip, E; Liddle, PF; Soucy, JP
      Need for a new framework to understand the mechanism of all antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 10:11:00